Biotechnology Focus Podcast

Over 1 billion people around the world suffer from "needle phobia." Each year, there are countless people who avoid critical therapies and vaccinations simply because of their fear of hypodermic needles. Vancouver's Microdermics Inc.is determined to change all that with its work on an innovative drug delivery system which promises to be safer, less painful, and more cost-effective than traditional hypodermic needles. In this episode of the Biotechnology Focus Podacst, Rory St. Claire, director of technical operations at Microdermics, talks about the unique features of his company's proposed alternative to a medical tool that has been known to make even grown men cry for more than 160 years.